{
  "docId": "019de077-1ff4-742f-85a8-f59ce4deae79",
  "docSlug": "52ed73af8fa71ea09355a28c443a9bf1",
  "documentTitle": "Kenvue | Results Presentation Deck | 42 slides",
  "authorId": "kenvue",
  "authorName": null,
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 7,
  "pageCount": 42,
  "prevPage": 6,
  "nextPage": 8,
  "slideType": "kpi_overview",
  "function": "analyze_data",
  "density": "dense",
  "nDataPoints": 2,
  "notes": "The slide uses a three-column layout to summarize segment performance alongside brand product shots.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de077-1ff4-742f-85a8-f59ce4deae79/7",
  "deckHref": "/decks/019de077-1ff4-742f-85a8-f59ce4deae79",
  "deckJsonHref": "/decks/019de077-1ff4-742f-85a8-f59ce4deae79.json",
  "deckAnchorHref": "/decks/019de077-1ff4-742f-85a8-f59ce4deae79#slide-7",
  "components": [
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.14,
        "y": 0.92
      },
      "kind": "disclaimer",
      "text": "1 Non-GAAP financial measure; refer to reconciliations of non-GAAP financial measures included in accompanying schedules to this presentation and to the earnings release available at investors.kenvue.com",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "0c780c1f-df60-454b-999c-06113c7c3efa",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.85,
        "w": 0.48,
        "x": 0.5,
        "y": 0.06
      },
      "kind": "image",
      "text": "Product imagery of Johnson's, Aveeno, Nicorette, and Tylenol",
      "attrs": null,
      "subkind": "photo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df455e58-bd98-4868-807f-08b19fdbc845",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.48,
        "x": 0.03,
        "y": 0.24
      },
      "kind": "list",
      "text": "Self Care: Delivered another strong quarter of Organic growth with global share gains. Skin Health & Beauty: Began executing actions to stabilize business in U.S. Essential Health: Continued momentum as strong product innovation resonated with consumers.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "7271a960-33c3-4389-9c2b-7459793eb90a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.55,
        "x": 0.03,
        "y": 0.11
      },
      "kind": "title",
      "text": "1.9% Organic growth on top of 11.2% growth in prior year",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "507a844e-b44b-419a-acf8-9855a5f4ce0c",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.35,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "Q1 2024 Organic growth",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "09c4e251-3a3f-4608-b710-9742a8c57589",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "2598b5a9-e463-4307-9052-289a32fb7b35",
      "evidence": "1.9% Organic growth on top of 11.2% growth in prior year",
      "confidence": 0.8
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 10,
      "from": 6,
      "beatId": "c70512c4-582a-401e-bb22-c8659b87c9b2",
      "arcName": "Monroe's Motivated Sequence",
      "arcSlug": "monroes-sequence",
      "beatName": "Need",
      "beatSlug": "monroes-sequence-need",
      "evidence": "The document highlights Kenvue's Q1 2024 highlights and strategic priorities, establishing a need for growth.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 10,
      "from": 6,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "9007875d-642e-44b4-842f-03d919fa182f",
      "evidence": "The document emphasizes the need for growth and the importance of Kenvue's strategic priorities.",
      "position": 0,
      "objective": "Highlighting the importance of Kenvue's strategic priorities",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.6,
      "description": "Quantify what happens if the audience does nothing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}